Legal Opinion
Rohn v. TAP Pharmaceutical Products, Inc.
Court of Appeals for the First Circuit
Decided April 24, 2012No. Nos. 10-2494, 11-1329PublishedCited by 2 opinions
1Opinion of the Court
LYNCH, Chief Judge.
Appellants, a small dissident group (“the Samsell plaintiffs”), are within a larger class of medical patient consumers in a case alleging fraud in overcharging for the medication Lupron. These plaintiffs, along with insurers and private *24health care providers, have achieved a major settlement agreement which was approved by the district court. The total amount of the settlement was $150 million, of which $40 million was allocated to consumers. That agreement provided that if there were unclaimed monies from the $40 million consumer settlement pool even after full recovery to…
2Cases cited28 opinions
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Devlin v. ScardellettiSupreme Court of the United States · 2002
- Six (6) Mexican Workers v. Arizona Citrus Growers Bodine Produce Company, Inc. Robert Fletcher, D/B/A Fletcher FarmsCourt of Appeals for the Ninth Circuit · 1990
- Stringfellow v. Concerned Neighbors in ActionSupreme Court of the United States · 1987
- Texaco Puerto Rico, Inc. v. Department of Consumer AffairsCourt of Appeals for the First Circuit · 1995
23 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- In Re Lupron Marketing and Sales Practices Litig.Court of Appeals for the First Circuit · 2012
- United States v. UpshurDistrict Court, District of Columbia · 2019